Works matching IS 0008543X AND DT 2012 AND VI 118 AND IP 16


Results: 33
    1
    2
    3

    Beta blocker use and colorectal cancer risk.

    Published in:
    Cancer (0008543X), 2012, v. 118, n. 16, p. 3911, doi. 10.1002/cncr.26727
    By:
    • Jansen, Lina;
    • Below, Janina;
    • Chang-Claude, Jenny;
    • Brenner, Hermann;
    • Hoffmeister, Michael
    Publication type:
    Article
    4
    5
    6
    7
    8
    9

    Keeping it small.

    Published in:
    Cancer (0008543X), 2012, v. 118, n. 16, p. 3879, doi. 10.1002/cncr.27766
    By:
    • Printz, Carrie
    Publication type:
    Article
    10

    Statin use and fatal prostate cancer.

    Published in:
    Cancer (0008543X), 2012, v. 118, n. 16, p. 4046, doi. 10.1002/cncr.26720
    By:
    • Marcella, Stephen W.;
    • David, Alice;
    • Ohman-Strickland, Pamela A.;
    • Carson, Jeffery;
    • Rhoads, George G.
    Publication type:
    Article
    11

    NRAS mutation status is an independent prognostic factor in metastatic melanoma.

    Published in:
    Cancer (0008543X), 2012, v. 118, n. 16, p. 4014, doi. 10.1002/cncr.26724
    By:
    • Jakob, John A.;
    • Bassett, Roland L.;
    • Ng, Chaan S.;
    • Curry, Jonathan L.;
    • Joseph, Richard W.;
    • Alvarado, Gladys C.;
    • Rohlfs, Michelle L.;
    • Richard, Jessie;
    • Gershenwald, Jeffrey E.;
    • Kim, Kevin B.;
    • Lazar, Alexander J.;
    • Hwu, Patrick;
    • Davies, Michael A.
    Publication type:
    Article
    12
    13

    Cancer mortality-to-incidence ratios in Georgia.

    Published in:
    Cancer (0008543X), 2012, v. 118, n. 16, p. 4032, doi. 10.1002/cncr.26728
    By:
    • Wagner, Sara E.;
    • Hurley, Deborah M.;
    • Hébert, James R.;
    • McNamara, Chrissy;
    • Bayakly, A. Rana;
    • Vena, John E.
    Publication type:
    Article
    14
    15
    16
    17

    A phase 2 trial of combination therapy with thalidomide, arsenic trioxide, dexamethasone, and ascorbic acid (TADA) in patients with overlap myelodysplastic/myeloproliferative neoplasms (MDS/MPN) or primary myelofibrosis (PMF).

    Published in:
    Cancer (0008543X), 2012, v. 118, n. 16, p. 3968, doi. 10.1002/cncr.26741
    By:
    • Bejanyan, Nelli;
    • Tiu, Ramon V.;
    • Raza, Azra;
    • Jankowska, Ania;
    • Kalaycio, Matt;
    • Advani, Anjali;
    • Chan, Josephine;
    • Saunthararajah, Yogen;
    • Mooney, Lindsey;
    • Maciejewski, Jaroslaw P.;
    • Sekeres, Mikkael A.
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy.

    Published in:
    Cancer (0008543X), 2012, v. 118, n. 16, p. 4053, doi. 10.1002/cncr.26729
    By:
    • Zafarana, Gaetano;
    • Ishkanian, Adrian S.;
    • Malloff, Chad A.;
    • Locke, Jennifer A.;
    • Sykes, Jenna;
    • Thoms, John;
    • Lam, Wan L.;
    • Squire, Jeremy A.;
    • Yoshimoto, Maisa;
    • Ramnarine, Varune Rohan;
    • Meng, Alice;
    • Ahmed, Omar;
    • Jurisca, Igor;
    • Milosevic, Michael;
    • Pintilie, Melania;
    • van der Kwast, Theo;
    • Bristow, Robert G.
    Publication type:
    Article
    31
    32
    33